Carasent AB (CARA) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

customers within Adopus and the largest one, Fetix, is now really, really happy with the product and they're giving out testimonials saying how good the product is. You can see them on the LinkedIn and also other social media. And I think Adopus Web is a great product. We have to learn how to sell it, we have to learn how to increment in a good way to make it easy for customers. But once we do, we will be able to really sell. But what this organization do is set us in a cost structure that give us time to succeed with Adopus Web. And that's the main reason. And what that means is that the coming 12 months will not try to do any new sales of Adopus Web. We just try to move all customers from old Adopus to new Adopus Web. Then when we have happy customers in that solution, we can start selling to new customers. And then we have all these present customers talking about how they can make a difference. And we're working well about a new product. It's very difficult to do both at the same time. So we have to accept that back, lower the pace a bit in that organization, lower costs so we can take time to move customers over to the new product and then sell to new customers. And I think it would be a really beneficial structure to be in the same structure as Adurys. And that means then that the head of Adopus have had to leave the company and also another employee in that part of the organization. Looking at Metodica and that to the guys, what I see as our enterprise solution. So it's for really big caregivers that use the same system across multiple clinics and hospitals. And those type of caregivers, they usually want some adoption. So if you're looking at WebDoc, which is for single clinics or groups of clinics, we don't do any adoptions at all. But in Metodica, a large c...